Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Mycophenolate Mofetil
Ruxolitinib
Locations
1
United States
The University of Texas M. D. Anderson Cancer Center
Houston, Texas, United States
Start Date
July 22, 2025
Primary Completion Date
January 31, 2028
Completion Date
January 31, 2030
Last Updated
April 23, 2026
NCT05735717
NCT05768932
NCT06834282
NCT07486713
NCT06859424
NCT06994676
Lead Sponsor
M.D. Anderson Cancer Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions